Navigation Links
Lupin Limited: Quarter III Results, FY 2012-13
Date:1/31/2013

s. m

% of net % of net YoY Particulars Q3 2012-13 sales Q3 2011-12 sales growth % Net sales 24,659 100% 17,917 100.0% 37.6% Other operating income 352 1.4% 286 1.6% 23.2% Total revenue 25,011 101.4% 18,203 101.6% 37.4% Raw material consumed 9,357 37.9% 6,258 34.9% 49.5% Gross margin (excl. other operating income) 15,302 62.1% 11,659 65.1% 31.2% Employees cost 3,165 12.8% 2,524 14.1% 25.4% Manufacturing & other expenses 6,440 26.1% 5,673 31.7% 13.5% Operating margin 6,049 24.5% 3,748 20.9% 61.4% Other income 265 1.1% 20 0.1% 1245.8% EBITDA 6,314 25.6% 3,768 21.0% 67.6% Depreciation 688 2.8% 576 3.2% 19.4% EBIT 5,626 22.8% 3,192 17.8% 76.3% Interest & finance charges 76 0.3% 85 0.5% -10.4% PBT 5,550 22.5% 3,107 17.3% 78.6% Tax 2,116 8.6% 701 3.9% 201.8% PAT 3,434 13.9% 2,406 13.4% 42.7% Minority interest & share of loss in associates 82 0.3% 55 0.3% 48.4% Net profit 3,352 13.6% 2,351 13.1% 42.6%

Balance sheet highlights

  • Operating working capital increased to Rs. 22,855 m. as on 31st December, 2012 as against Rs. 21,322 m. as on 30th September, 2012.  The working capital number of days stands at 90 days as on 31st December, 2012 as against 87 days on 30th September, 2012.
  • Capital Expenditure stood at Rs. 970 m. during the quarter.
  • Debt Equity Ratio as on 31st December, 2012, was 0.21.

YOY growth Particulars Q3 2012-13 Q3 2011-12 % Formulations 22,306 15,936 40% US (including IP) 10,390 6,188 68% Europe 598 644 -7% India 5,708 5,011 14% Japan 3,658 2,468 48% South Africa 831 583 43% Rest of world 1,121 1,042 8% API 2,353 1,981 19% Total net sales 24,659 17,917 38%

US & Europe

US & Europe formulation sales contributed 44% to the Company's overall consolidated revenues for Q3 FY 2012-13. Formulation Sal
'/>"/>

SOURCE Lupin Ltd
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Building on a Legacy: Vinita Gupta, CEO of Lupin Pharmaceuticals, Inc., Named Ernst & Young U.S. 2012 Family Business Award of Excellence winner
2. CryoLife Announces Release Date and Teleconference Call Details for 2012 Fourth Quarter and Year End Financial Results
3. Valeant Pharmaceuticals To Announce 2012 Fourth Quarter Results On February 28, 2013
4. TPI to Host Second Quarter of Fiscal Year 2013 Earnings Conference Call on Thursday, February 14, 2013 at 8:30 a.m. ET
5. Zimmer Reports Fourth Quarter and 2012 Financial Results
6. VirtualScopics Schedules Fourth Quarter and Full Year 2012 Earnings Announcement
7. Masimo to Report Fourth Quarter and Full Year 2012 Financial Results after Market Close on Thursday, February 14
8. The Female Health Company Reports Record First Quarter FY2013 Operating Results
9. Avanir Pharmaceuticals Announces Date Of Fiscal 2013 First Quarter Financial Results And Conference Call
10. Genomic Health to Announce Fourth Quarter and Year-End 2012 Financial Results and Host Conference Call on Wednesday, February 6, 2013
11. PDL BioPharma Announces 2013 Regular Quarterly Dividends
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 2014 Baptist Health Lexington is the first facility ... full Atrial Fibrillation with Electrophysiology Services (EPS) Accreditation status from ... fibrillation is the most common cardiac arrhythmia and has become ... lead to stroke and possible death. More than 5 million ... atrial fibrillation and the numbers are rapidly increasing as the ...
(Date:12/19/2014)... , Dec. 19, 2014  Eli Lilly and ... Paris: FR0011184241 – ADOC) today announced a worldwide licensing ... BioChaperone Lispro, for treatment in people with type 1 ... proprietary BioChaperone® technology and is currently in Phase Ib ... Lispro with the goal of optimizing glucose levels during ...
(Date:12/17/2014)... STUTTGART , Alemania, December 17, 2014 ... del año anterior, con un alto nivel de gasto ... pasado año fiscal 2013/14 (finalizado el 30 de septiembre ... por ciento a 4.287 millones de euros (año anterior: ... de la moneda desfavorables. Las ganancias (EBIT) crecieron un ...
Breaking Medicine Technology:Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 2Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 3Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 2Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 3ZEISS confirma su posición en un entorno difícil 2
... Feb. 9 LightLab Imaging, Inc., pioneer and ... coronary artery applications, today reported that Trial Judge Margaret ... commencement of the next phase of an ongoing trial to ... its wholly owned subsidiary, Axsun Technologies, Inc.  After a four ...
... Feb. 9 Mylan Inc. (Nasdaq: MYL ) ... has received Verified-Accredited Wholesale Distributors® (VAWD) accreditation from the National ... VAWD program in 2004 to help protect the public from ... , Mylan North America President Hal Korman stated: ...
Cached Medicine Technology:Date Set for LightLab Damages Trial Against Volcano and Axsun 2Mylan Awarded NABP-VAWD Accreditation for Its Primary North American Distribution Facility 2
(Date:12/22/2014)... Only weeks following the announcement that ... to have a battery manufacturer create 29 well-paying jobs ... ) is launching in Henderson to deliver yet ... strong manufacturing sector is going to build a stronger ... “and TalkLocal works with small businesses that rely on ...
(Date:12/22/2014)... York NY (PRWEB) December 22, 2014 ... that a federal panel of judges has granted a ... in the U.S. District Court, Eastern District of ... issued an order on December 12 to transfer over ... in 22 districts to the Louisiana court for consolidation ...
(Date:12/22/2014)... City, NY (PRWEB) December 22, 2014 ... as a 2014 Professional Woman of the Year. Ms. ... in business. As the largest, most-recognized networking organization of ... and profession, the National Association of Professional Women is ... and nearly 300 Local Chapters. , “As a nurse, ...
(Date:12/22/2014)... Parker & Sons, Inc. a reliable and ... contracting services reports a record number of favorable reviews ... 2014. As a company that has served the greater ... Sons is a business that is focused on excellent ... other top quality companies in Arizona that are focused ...
(Date:12/21/2014)... 21, 2014 Khanna Vision Institute is ... at the Aspen Helicopters holiday event for underprivileged kids. ... with sleigh, flown by an aspen helicopter pilot. In ... Santa with sleigh was visible.(please see accompanying video). Helicopter ... Dr.Khanna has helped many pilots with Pi in eye ...
Breaking Medicine News(10 mins):Health News:TalkLocal Launches in Henderson Weeks Following New Megafactory, New Jobs Announcement 2Health News:Panel Orders Xarelto Lawsuits Consolidated Into Multi-District Litigation Reports Alonso Krangle LLP 2Health News:Panel Orders Xarelto Lawsuits Consolidated Into Multi-District Litigation Reports Alonso Krangle LLP 3Health News:Panel Orders Xarelto Lawsuits Consolidated Into Multi-District Litigation Reports Alonso Krangle LLP 4Health News:National Association of Professional Women Announces Michelle M. Foley, Vice President of Operations of OTTR Chronic Care Solutions, a 2014 Professional Woman of the Year 2Health News:Parker & Sons Reports A Record Number Of Favorable References With Regard To Its Quality Services In 2014 2Health News:Parker & Sons Reports A Record Number Of Favorable References With Regard To Its Quality Services In 2014 3
... , , , ... TELEHOUSE America ( www.telehouse.com ) ... exchanges, and managed IT services, today announced it is offering ... prevention (DLP) consulting services as part of its Manage-E ...
... THURSDAY, July 23 (HealthDay News) -- Postmenopausal women with ... developing breast cancer, a new study says. , Researchers ... in New York City found a strong association between ... of breast cancer. Their findings were published online in ...
... , , , OWINGS ... today that it will release second quarter fiscal year 2009 financial results for ... the opening of the market. The Company will hold a conference call and ... a.m. ET. , , Interested parties can access ...
... /PRNewswire-FirstCall/ - AlphaRx, Inc. (OTCBB: ALRX) announced positive ... nanoparticle (Zysolin(TM)) formulation was a more effective treatment ... when compared to inhaled and injected conventional tobramycin ... oral podium session at the 36th Annual Meeting ...
... 23 MedCath Corporation (Nasdaq: MDTH ) will host a conference call Thursday, August ... 2009. The company will issue a press release announcing those results prior to the earnings call. ... Third Quarter Earnings Conference Call, When: ... Dial-in conference call, ...
... , , , ... results for the 2009 second quarter and first half ended June 30, 2009. ... quarter and decreased 5% to $11.1 billion for the 2009 first half. ... the 2009 second quarter and first half. , ...
Cached Medicine News:Health News:TELEHOUSE America Offers Integralis' Data Loss Prevention Consulting Services as Part of its Manage-E Solution 2Health News:TELEHOUSE America Offers Integralis' Data Loss Prevention Consulting Services as Part of its Manage-E Solution 3Health News:TELEHOUSE America Offers Integralis' Data Loss Prevention Consulting Services as Part of its Manage-E Solution 4Health News:Elevated Insulin Levels Linked to Breast Cancer 2Health News:Medifast, Inc. to Announce Second Quarter Fiscal Year 2009 Financial Results on Thursday, July 30, 2009 2Health News:AlphaRx Presents Positive Preclinical Data on Zysolin(TM) Inhalable Nanoparticles at Controlled Release Society Annual Meeting 2Health News:AlphaRx Presents Positive Preclinical Data on Zysolin(TM) Inhalable Nanoparticles at Controlled Release Society Annual Meeting 3Health News:MedCath Corporation to Hold Conference Call on Third Quarter Results 2Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 2Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 3Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 4Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 5Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 6Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 7Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 8Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 9Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 10Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 11Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 12Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 13Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 14Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 15Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 16
... Plus® 5.5 is excellent ... the optic nerve head ... with your binocular indirect ... neovascular membranes, macular edema, ...
The iQ200 Automated Urinalysis System (iQ System) is a user-friendly, bench top, fully automated system that performs complete urinalyses on unspun specimens; simply load, press START and walk away....
A flexible hematology platform:, 32 parameters, Automatic result validation, Cytology atlas included, CBC and 5+3 DIFF...
The PDM utilizes the latest technology for measuring interpupillary distance and left/right pupil-to-nose distance. Lightweight and easy-to-use, the PDM provides accurate and repeatable PD measuremen...
Medicine Products: